Zileuton
Product Images NDC 68180-169

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 68180-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-01 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 01)

Image-01 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 01)
Chemical structure diagram of zileuton, showing its molecular composition including a fused bicyclic ring with sulfur, hydroxyl, methyl, and carbamoyl groups.*
FDA Label Image

Image-02 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 02)

Image-02 (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 02)
A line graph depicting the mean change from baseline in trough FEV1 (L) over DB study weeks for Zileuton Extended-Release Tablets compared to placebo. The graph shows data points at weeks 0, 2, 4, 8, 12, and the study endpoint, with Zileuton showing a greater increase in FEV1 than placebo. Sample sizes (N) for each group at each time point are provided below the x-axis.*
FDA Label Image

Image (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 03)

Image (Ab244d5a E8e0 4aca B9b7 90bce5093e3c 03)
Zileuton Extended-Release Tablets 600 mg label from Lupin Pharmaceuticals, Inc. The label shows 60 tablets per container with instructions for pharmacists and storage conditions. It includes dosing instructions to take 2 tablets twice daily and cautions against chewing or crushing the tablets. Manufactured by Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.